Innovative light therapy reaches deep tumors
Researchers led by Samuel Achilefu, PhD, at the School of Medicine have devised a way to apply light-based therapy to deep tissues never before accessible. Instead of shining an outside light, they delivered light directly to tumor cells, along with a photosensitive source of free radicals that can be activated by the light to destroy cancer.
Nanoparticle that lights up artery-clogging plaque to be evaluated in clinical trial
The Food and Drug Administration (FDA) has approved for testing in people a nanoparticle-based imaging agent jointly developed at the School of Medicine and collaborating institutions. The imaging agent may illuminate dangerous plaque in arteries, and doctors hope to use it to identify patients at high risk of stroke.
Washington People: Sally Schwarz
The nuclear pharmacist with a flair for design is working to keep Mallinckrodt Institute of Radiology at the forefront of research and patient care.